In Situ Cocktail Nanovaccine for Cancer Immunotherapy

In situ vaccination is a desirable strategy for cancer immunotherapy due to its convenience and capacity to target tumor antigens. Here, an in situ nanovaccine based on a cationic peptide with cholesterol‐modified, DP7‐C, for cancer immunotherapy is rationally designed, and developed a cancer nanova...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mohan, Xie, Daoyuan, Hu, Die, Zhang, Rui, Wang, Yusi, Tang, Lin, Zhou, Bailing, Zhao, Binyan, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625102/
https://www.ncbi.nlm.nih.gov/pubmed/37740439
http://dx.doi.org/10.1002/advs.202207697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625102/
https://www.ncbi.nlm.nih.gov/pubmed/37740439
http://dx.doi.org/10.1002/advs.202207697

Ejemplares similares